Advanced Medical Solutions Group plc (AIM:AMS)
London · Delayed Price · Currency is GBP · Price in GBX 226.00
+18.50 (8.92%)
At close: Dec 5, 2025
AIM:AMS Market Cap
AIM:AMS has a market cap or net worth of 487.39 million as of December 5, 2025. Its market cap has increased by 8.29% in one year.
Market Cap
487.39M
Enterprise Value
551.12M
Revenue
220.30M
Ranking
n/a
PE Ratio
54.18
Stock Price
226.00
Market Cap Chart
Since April 11, 2000, AIM:AMS's market cap has increased from 11.11M to 487.39M, an increase of 4,288.14%. That is a compound annual growth rate of 15.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 487.39M | 15.06% |
| Dec 31, 2024 | 423.58M | -6.07% |
| Dec 29, 2023 | 450.96M | -19.69% |
| Dec 30, 2022 | 561.49M | -23.12% |
| Dec 31, 2021 | 730.32M | 39.54% |
| Dec 31, 2020 | 523.38M | -17.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 73.29B |
| Haleon | 32.02B |
| Smith & Nephew | 10.44B |
| Convatec Group | 4.49B |
| Hikma Pharmaceuticals | 3.53B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.77B |